Found: 100
Select item for more details and to access through your institution.
Prognostic impact of KMT2A‐AFF1‐positivity in 926 BCR‐ABL1‐negative B‐lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. E334, doi. 10.1002/ajh.26253
- By:
- Publication type:
- Article
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1466, doi. 10.1002/ajh.25957
- By:
- Publication type:
- Article
Second cancers in MPN: Survival analysis from an international study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 3, p. 295, doi. 10.1002/ajh.25700
- By:
- Publication type:
- Article
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second‐generation tyrosine kinase inhibitors in the real‐life practice: Identification of risk factors and the role of prophylaxis.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 7, p. E159, doi. 10.1002/ajh.25102
- By:
- Publication type:
- Article
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 8, p. 797, doi. 10.1002/ajh.24774
- By:
- Publication type:
- Article
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 7, p. 692, doi. 10.1002/ajh.24382
- By:
- Publication type:
- Article
Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 7, p. E135, doi. 10.1002/ajh.24022
- By:
- Publication type:
- Article
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 1, p. 22, doi. 10.1002/ajh.22189
- By:
- Publication type:
- Article
Systemic Mastocytosis: Multidisciplinary Approach.
- Published in:
- Mediterranean Journal of Hematology & Infectious Diseases, 2021, v. 13, n. 1, p. 1, doi. 10.4084/MJHID.2021.068
- By:
- Publication type:
- Article
Management of polycythemia vera: A survey of treatment patterns in Italy.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 2, p. 161, doi. 10.1111/ejh.13889
- By:
- Publication type:
- Article
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemia.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 3, p. 286, doi. 10.1111/ejh.13436
- By:
- Publication type:
- Article
"Variant‐specific discrepancy when quantitating BCR‐ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay." Is dPCR the key?
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 3, p. 272, doi. 10.1111/ejh.13282
- By:
- Publication type:
- Article
Successful preservation of BCR‐ABL1 protein and direct measure of kinase activity in peripheral blood of CML and Ph+ ALL patients unveil a kinase inhibitory activity present in CML cells.
- Published in:
- FASEB Journal, 2021, v. 35, p. N.PAG, doi. 10.1096/fasebj.2021.35.S1.05429
- By:
- Publication type:
- Article
Perspectives and Emotional Experiences of Patients With Chronic Myeloid Leukemia During ENESTPath Clinical Trial and Treatment-Free Remission: Rationale and Protocol of the Italian Substudy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.638689
- By:
- Publication type:
- Article
Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. 1, doi. 10.3389/fonc.2020.00883
- By:
- Publication type:
- Article
Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 7, p. 2298, doi. 10.3390/ijms21072298
- By:
- Publication type:
- Article
Dickkopf-1 and Sclerostin Serum Levels in Patients with Systemic Mastocytosis.
- Published in:
- Calcified Tissue International, 2015, v. 96, n. 5, p. 410, doi. 10.1007/s00223-015-9969-5
- By:
- Publication type:
- Article
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 5, p. 323, doi. 10.1016/j.clml.2024.01.008
- By:
- Publication type:
- Article
MPN-180: A Novel Mechanism of Action of Midostaurin in Systemic Mastocytosis: Beyond KIT Inhibition.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S356, doi. 10.1016/S2152-2650(21)01823-1
- By:
- Publication type:
- Article
CML-182: SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S329, doi. 10.1016/S2152-2650(21)01772-9
- By:
- Publication type:
- Article
Poster: MPN-180: A Novel Mechanism of Action of Midostaurin in Systemic Mastocytosis: Beyond KIT Inhibition.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S233, doi. 10.1016/S2152-2650(21)01468-3
- By:
- Publication type:
- Article
Poster: CML-182: SETD2 Loss of Function Induces Genomic Instability in CML and May Contribute to Disease Progression to Blast Crisis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S225, doi. 10.1016/S2152-2650(21)01419-1
- By:
- Publication type:
- Article
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2012, v. 461, n. 6, p. 677, doi. 10.1007/s00428-012-1322-z
- By:
- Publication type:
- Article
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project.
- Published in:
- 2018
- By:
- Publication type:
- journal article
SETD2 non genomic loss of function in advanced systemic mastocytosis is mediated by an Aurora kinase A/MDM2 axis and can be therapeutically targeted.
- Published in:
- Biomarker Research, 2023, v. 11, n. 1, p. 1, doi. 10.1186/s40364-023-00468-7
- By:
- Publication type:
- Article
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01025-7
- By:
- Publication type:
- Article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00834-6
- By:
- Publication type:
- Article
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Breakthrough infections in MPN-COVID vaccinated patients.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 11, p. 1, doi. 10.1038/s41408-022-00749-8
- By:
- Publication type:
- Article
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 6, p. 1, doi. 10.1038/s41408-020-0333-2
- By:
- Publication type:
- Article
Plasmacytoid Dendritic Cell Leukemia: A Rapidly Evolving Disease Presenting with Skin Lesions Sensitive to Radiotherapy plus Hyperthermia.
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1205, doi. 10.1634/theoncologist.2009-0184
- By:
- Publication type:
- Article
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis.
- Published in:
- Clinical Case Reports, 2017, v. 5, n. 12, p. 1988, doi. 10.1002/ccr3.1232
- By:
- Publication type:
- Article
Editorial: Risk-stratification in myelodysplastic syndromes .
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1095847
- By:
- Publication type:
- Article
Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 11, p. 1527, doi. 10.1080/0284186X.2021.1971292
- By:
- Publication type:
- Article
α-bisabolol Is an Effective Proapoptotic Agent against BCR-ABL<sup>+</sup> Cells in Synergism with Imatinib and Nilotinib.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0046674
- By:
- Publication type:
- Article
CXCL12 and [N33A]CXCL12 in 5637 and HeLa Cells: Regulating HER1 Phosphorylation via Calmodulin/Calcineurin.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034432
- By:
- Publication type:
- Article
Patient‐reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 2, p. 287, doi. 10.1002/cncr.35021
- By:
- Publication type:
- Article
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic‐phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 17, p. 2637, doi. 10.1002/cncr.34923
- By:
- Publication type:
- Article
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic‐phase myelofibrosis.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 13, p. 2449, doi. 10.1002/cncr.34216
- By:
- Publication type:
- Article
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 4, p. 637, doi. 10.1111/bjh.19104
- By:
- Publication type:
- Article
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 4, p. 440, doi. 10.1111/bjh.18537
- By:
- Publication type:
- Article
Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX‐IOL study.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 2, p. 190, doi. 10.1111/bjh.18057
- By:
- Publication type:
- Article
COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 559, doi. 10.1111/bjh.17890
- By:
- Publication type:
- Article
Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 845, doi. 10.1111/bjh.17405
- By:
- Publication type:
- Article
Next‐generation sequencing improves BCR‐ABL1 mutation detection in Philadelphia chromosome‐positive acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 271, doi. 10.1111/bjh.17301
- By:
- Publication type:
- Article
Second primary malignancy in myelofibrosis patients treated with ruxolitinib.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 356, doi. 10.1111/bjh.17192
- By:
- Publication type:
- Article
Philadelphia‐positive acute lymphoblastic leukaemia (ALL) in Italy during the COVID‐19 pandemic: a Campus ALL study.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 1, p. e3, doi. 10.1111/bjh.16758
- By:
- Publication type:
- Article
A journey through infectious risk associated with ruxolitinib.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 3, p. 286, doi. 10.1111/bjh.16174
- By:
- Publication type:
- Article